Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer

Christopher D. Cox(United States Military Academy), George D. Hartman(Joint BioEnergy Institute), Thomayant Prueksaritanont(United States Military Academy), Paul J. Coleman(United States Military Academy), Robert B. Lobell(United States Military Academy), Marc Abrams(Dicerna Pharmaceuticals (United States)), Nancy E. Kohl(United States Military Academy), Carmen Fernández‐Metzler(United States Military Academy), Kelly Hamilton(United States Military Academy), Eileen S. Walsh(United States Military Academy), R. M. Garbaccio(United States Military Academy), Elizabeth Mahan(United States Military Academy), Vicki J. South(United States Military Academy), David B. Whitman(United States Military Academy), Ronald E. Diehl(United States Military Academy), Carolyn A. Buser(United States Military Academy), Chunze Li(Nanyang Technological University), Joseph P. Davide(United States Military Academy), Michael J. Breslin(United States Military Academy), Maricel Torrent(United States Military Academy), Youwei Yan(United States Military Academy), Lawrence C. Kuo(United States Military Academy), Donald E. Slaughter(United States Military Academy), Michael D. Schaber(United States Military Academy), Mark E. Fraley(United States Military Academy), Weikang Tao(Shanghai Medical Information Center), Hans E. Huber(Health Strat (Kenya))
Journal of Medicinal Chemistry
June 25, 2008
Cited by 156


Related Papers